Compare PTCT & GEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | GEF |
|---|---|---|
| Founded | 1998 | 1877 |
| Country | United States | United States |
| Employees | N/A | 15660 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.7B |
| IPO Year | 2006 | 1994 |
| Metric | PTCT | GEF |
|---|---|---|
| Price | $61.16 | $82.90 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 5 |
| Target Price | ★ $100.40 | $87.60 |
| AVG Volume (30 Days) | ★ 1.0M | 328.0K |
| Earning Date | 10-29-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 3.02% |
| EPS Growth | ★ 264.48 | N/A |
| EPS | ★ 0.34 | N/A |
| Revenue | $264,734,000.00 | ★ $5,448,100,000.00 |
| Revenue This Year | N/A | $1.20 |
| Revenue Next Year | $8.21 | $2.73 |
| P/E Ratio | $177.71 | ★ $4.09 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $58.80 | $55.90 |
| 52 Week High | $90.87 | $90.57 |
| Indicator | PTCT | GEF |
|---|---|---|
| Relative Strength Index (RSI) | 43.92 | 53.39 |
| Support Level | $58.80 | $81.98 |
| Resistance Level | $63.74 | $85.08 |
| Average True Range (ATR) | 2.33 | 2.41 |
| MACD | 0.22 | 0.21 |
| Stochastic Oscillator | 31.73 | 48.65 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.